Life Sciences

99 VCs and 58 funds investing in Life Sciences

VCs investing in Life Sciences

Nimi Katragadda

Partner

88%

BoxGroup

Check: BoxGroup currently publishes a firm-wide maximum investment of $1M. Historical sources reported smaller firm checks and third-party profiles estimate $250K–$750K for Nimi, but no primary source confirms a current personal range.

Nimi is a generalist early-stage Partner with a long-running, publicly documented focus on healthcare and life sciences, fintech, marketplaces, and software. Her current activity extends that lens into AI-native healthcare, scientific agents, enterprise AI, and the financial infrastructure surrounding AI use. She applies BoxGroup's founder-first philosophy while testing whether the operating model, retention, sequencing, and economics can support the founder's category-scale ambition.

Pre-SeedSeedSeries A

Meagan Malm

Partner and Director of Operations

80%

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Meagan Malm is listed in a Partner and Director of Operations capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

SeedEarly Stage

Jessica Owens

Co-Founder and General Partner

80%

INITIATE Ventures

Check: $500K-$3M checks were disclosed at launch; no person-specific range is public.

Jessica Owens invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company initiation by experienced healthcare operators.

InceptionPre-SeedSeed

Riley Shelton

Associate, Investments

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Riley Shelton invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Iana Dimkova

Co-Founder and General Partner

80%

INITIATE Ventures

Check: $500K-$3M checks were disclosed at launch; no person-specific range is public.

Iana Dimkova invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company initiation by experienced healthcare operators.

InceptionPre-SeedSeed

Melinda Gloriosa

Vice President, Investments

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Melinda Gloriosa invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Srini Koushik

Venture Partner, AI

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Srini Koushik invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Justin Probst

Vice President, Finance and Operations

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Justin Probst is listed in a Vice President, Finance and Operations capacity at R1 Capital. The firm does not publish a person-specific investment thesis for this role; the profile therefore preserves the role distinction and uses the firm's public mandate only as shared context.

Proof of ConceptPre-SeedSeed

Meghan Hoffman

Associate, Life Sciences Investments

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Meghan Hoffman invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Omar Yamout

Associate

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Omar Yamout invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

Grant Berliner

Associate, Investments

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Grant Berliner invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Parker MacDonell

Venture Partner

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Parker MacDonell invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Wayne Embree

Venture Partner

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Wayne Embree invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Verlensia Bates

Accounting and Operations Coordinator

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Verlensia Bates is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Ken Hall

Vice President

80%

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Ken Hall is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

SeedSeries A

Howard Cox

Special Limited Partner

80%

Greylock Partners

Check: No current personal or Greylock check range is attributable to Howard, and his emeritus Special Limited Partner status should not be treated as current check-writing authority. Contact Greylock's active investors for stage, allocation, ownership and process.

Howard's record reflects a long-horizon institution-builder and governance lens developed across Greylock, the NVCA, In-Q-Tel, Stryker, investment committees and public-interest institutions. It is useful for evaluating leadership, board quality, stewardship and the relationship between private innovation and enduring institutions, but it is historical/advisory—not a current personal sourcing thesis.

Historical Venture InvestingBoard GovernanceInstitutional Investment Oversight

Shahram Seyedin-Noor

Founder + Managing Partner

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Shahram Seyedin-Noor invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

Sonia Setayesh

Investment Partner

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Sonia Setayesh invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

Manuel Lopez-Figueroa

Operating Partner

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Manuel Lopez-Figueroa invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

Sarah Loveland

Senior Associate

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Sarah Loveland invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

Angelica Parente

Operating Partner

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Angelica Parente invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

David Narrow

Venture Advisor

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

David Narrow is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Carli Kaleta

Associate Intern

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Carli Kaleta invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Pre-SeedSeed

Matt Wheeler

CFO

80%

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Matt Wheeler is listed in a CFO capacity at Civilization Ventures. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizational context.

Pre-SeedSeed

Mark Gorenberg

Founder & Managing Director

80%

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Mark Gorenberg invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Pre-SeedSeedEarly Stage

Apoorva Pandhi

Managing Director

80%

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Apoorva Pandhi invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Pre-SeedSeedEarly Stage

Jocelyn Goldfein

Managing Director

80%

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Jocelyn Goldfein invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Pre-SeedSeedEarly Stage

Dylan Reid

Managing Director

80%

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Dylan Reid invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Pre-SeedSeedEarly Stage

Annelies Gamble

Partner

80%

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Annelies Gamble invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Pre-SeedSeedEarly Stage

Mitchel Laskey

Managing Partner

80%

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Mitchel Laskey is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

SeedSeries A

Scott Addonizio

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Scott Addonizio is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Will Cadell

Venture Advisor

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Will Cadell is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Andy Dearing

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Andy Dearing is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Joel Crater

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Joel Crater is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Caleb Eidem

General Counsel

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Caleb Eidem is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Scott Herman

Venture Advisor

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Scott Herman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Elise Miller Hoffman

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Elise Miller Hoffman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Cliff Holekamp

Co-Founder & General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Cliff Holekamp is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Kristina Hood

Principal

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Kristina Hood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Kyle Kerns

CFO and Operations Lead

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Kyle Kerns is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Catherine Matthes

Venture Advisor

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Catherine Matthes is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Brian Matthews

Co-Founder & General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Brian Matthews is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Paul Meier

Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Paul Meier is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Sean Morris

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Sean Morris is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Dennis Muilenburg

Venture Advisor

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Dennis Muilenburg is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Jacob Schpok

Partner and Head of Platform

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Jacob Schpok is listed in a Partner and Head of Platform capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Matt Phimphavong

Principal

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Matt Phimphavong is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Grant Pothast

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Grant Pothast is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Rick Ryan

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Rick Ryan is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Bobby Sandage

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Bobby Sandage is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Martha Schlicher

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Martha Schlicher is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Barry Sandweiss

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Barry Sandweiss is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Bill Schmidt

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Bill Schmidt is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

David Smoller

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

David Smoller is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Timothy Stern

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Timothy Stern is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

John True

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

John True is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Paul Weber

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Paul Weber is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Kyle Welborn

Co-Founder & General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Kyle Welborn is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Heather Wood

General Partner

80%

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Heather Wood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

SeedSeries ASeries B

Ben Patz

Managing Partner

80%

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Ben Patz is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

SeedSeries A

Kathy Chiu

Managing Partner

80%

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Kathy Chiu is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

SeedSeries A

Kim Garland

Venture Partner

80%

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Kim Garland invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Proof of ConceptPre-SeedSeed

Jody Vanderwel

Founding Partner

80%

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Jody Vanderwel invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

SeedEarly Stage

Jackson Streeter, MD

Venture Partner

80%

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Jackson Streeter, MD is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

SeedSeries A

Kristopher Lancaster

Associate

80%

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Kristopher Lancaster is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

SeedSeries A

Stacey Barnes

Senior Business Operations Manager

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Stacey Barnes is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Henry Haverty

Accounting Intern

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Henry Haverty is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Logan Hille, Ph.D.

Life Sciences Analyst

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Logan Hille, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Kerry Hull, CPA, MBA

Chief Financial Officer & Chief Operating Officer

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Kerry Hull, CPA, MBA is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Sean Kwiat

Vice President, Investments

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Sean Kwiat is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Liam McAllister

Investment Analyst

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Liam McAllister is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Bryan McCleary

Executive in Residence

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Bryan McCleary is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Kenneth Morand, Ph.D.

Life Sciences Partner

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Kenneth Morand, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Emma Off

CEO, President, & Partner

80%

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Emma Off is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Pre-SeedSeedSeries A

Maureen Stancik Boyce, PhD

Managing Partner

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Maureen Stancik Boyce, PhD is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

Amy Salzhauer

Managing Partner

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Amy Salzhauer is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

Carolyne LaSala

Managing Partner

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Carolyne LaSala is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

David Mendez

Managing Partner

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

David Mendez is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

Sophie Hagerty

Principal

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Sophie Hagerty is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

Aditi Rajagopal

Principal

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Aditi Rajagopal is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

Ziad Sarby

Associate

80%

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Ziad Sarby is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Pre-SeedSeedSeries A

Marc Averitt

Co-Founder, Managing Director

80%

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

Marc Averitt invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

SeedEarly Stage

Jeff Bocan

Managing Director

80%

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

Jeff Bocan invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

SeedEarly Stage

John Waller

Managing Director, Venture Partner

80%

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

John Waller invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

SeedEarly Stage

Sharon Stevenson

Co-Founder, Managing Director, Venture Partner

80%

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

Sharon Stevenson invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

SeedEarly Stage

Hayes Barnes

Director of Marketing

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Hayes Barnes is listed in a Director of Marketing capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Marli Carmack

Office Manager

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Marli Carmack is listed in a Office Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Andie Hines-Lagemann

Director of Engagement and EQ Practitioner

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Andie Hines-Lagemann invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Pre-SeedSeedEarly Stage

Chris Huxhold

Chief Financial Officer

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Chris Huxhold is listed in a Chief Financial Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Brighid King

Platform Operations Manager

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Brighid King is listed in a Platform Operations Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Nicholas Kuhn

Vice President of Hardtech

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Nicholas Kuhn invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Pre-SeedSeedEarly Stage

Phil Lodato

General Counsel and Chief Compliance Officer

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Phil Lodato is listed in a General Counsel and Chief Compliance Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Makenzie Norris

Vice President of Life Sciences

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Makenzie Norris invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Pre-SeedSeedEarly Stage

Dale Grogan

Managing Partner

80%

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Dale Grogan invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

SeedEarly Stage

Erica Schweyer

Chief of Staff

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Erica Schweyer is listed in a Chief of Staff capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Muhammad Yasin

Chief Marketing Officer

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Muhammad Yasin is listed in a Chief Marketing Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Landon Young

Vice President of Pre-Seed

80%

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Landon Young invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Pre-SeedSeedEarly Stage

Paul D'Amato

Chief Executive Officer and Founding Partner

80%

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Paul D'Amato invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

SeedEarly Stage

Lynn Bishop

Operating Partner

80%

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Lynn Bishop invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

SeedEarly Stage

Funds focused on Life Sciences

Forbion

Naarden, Netherlands

109 people0 investments

Cambridge Innovation Capital

Cambridge, United Kingdom

55 people0 investments

Inveready

Barcelona, Spain

54 people0 investments

Bayern Kapital

Landshut, Bavaria, Germany

52 people0 investments

Anzu Partners

Boston / San Diego / Tampa / Washington, DC / Atlanta

AUM: Approximately $1B

41 people0 investments

Portugal Ventures

Porto and Lisbon, Portugal

42 people0 investments

Elaia

Paris, France

41 people0 investments

Seventure Partners

Paris, France

36 people0 investments

Investinor

Trondheim, Norway

33 people0 investments

PSV

Kongens Lyngby, Denmark

31 people0 investments

Cultivation Capital

St. Louis, Missouri

30 people0 investments

Innovestor

Helsinki, Finland

28 people0 investments

Industrifonden

Stockholm, Sweden

26 people0 investments

Parkwalk Advisors

London, United Kingdom

24 people0 investments

M Ventures

Amsterdam, Netherlands

23 people0 investments

Wellington Partners

Munich, Germany

23 people0 investments

DeepTech & Climate Fonds

Berlin, Bonn and Munich, Germany

22 people0 investments

Elevate Ventures

Indianapolis, Indiana

22 people0 investments

Innovation Industries

Amsterdam, Netherlands

22 people0 investments

NRW.Venture

Düsseldorf, Germany

21 people0 investments

BioGeneration Ventures

Naarden, Netherlands

20 people0 investments

Hadean Ventures

Oslo, Norway and Stockholm, Sweden

18 people0 investments

Mercia Ventures

United Kingdom

19 people0 investments

Michigan Capital Network

Grand Rapids, Michigan

17 people0 investments

Vi Partners

Switzerland

16 people0 investments

Newton Biocapital

Brussels, Belgium and Tokyo, Japan

15 people0 investments

Safar Partners

Cambridge, Massachusetts

14 people0 investments

Brandenburg Kapital

Potsdam, Germany

14 people0 investments

Claris Ventures

Turin, Italy

14 people0 investments

Panakès Partners

Milan, Italy

14 people0 investments

Clarevia

Madison, Wisconsin

12 people0 investments

Sandwater

Oslo, Norway

12 people0 investments

redalpine

Zurich, Switzerland

12 people0 investments

Sarsia

Bergen, Norway

12 people0 investments

Navigare Ventures

Stockholm, Sweden

11 people0 investments

R1 Capital

Columbus, Ohio

11 people0 investments

Heal Capital

Berlin, Germany

11 people0 investments

Michigan Rise

East Lansing, Michigan

10 people0 investments

XISTA Science Ventures

Vienna, Austria

11 people0 investments

CincyTech

Cincinnati, Ohio

9 people0 investments

Metavallon VC

Athens, Greece

9 people0 investments

Civilization Ventures

San Francisco, California

8 people0 investments

Thuja Capital

Utrecht, Netherlands

9 people0 investments

i&i Bio

Prague, Czechia

8 people0 investments

MassVentures

Waltham, Massachusetts / Worcester, Massachusetts

8 people0 investments

Practica Capital

Vilnius, Lithuania

8 people0 investments

Nordic Science Investments

Helsinki, Finland

7 people0 investments

DeepWork Capital

Orlando, Florida

6 people0 investments

Good Growth Capital

Charleston, South Carolina

7 people0 investments

V-Bio Ventures

Ghent, Belgium

7 people0 investments

Voima Ventures

Helsinki, Finland

7 people0 investments

Kickfund

Basel, Switzerland

6 people0 investments

Vesalius Biocapital

Luxembourg

5 people0 investments

OCCIDENT

Munich, Germany and Zug, Switzerland

4 people0 investments

Okapi Venture Capital

Newport Beach, California

4 people0 investments

Zetta Venture Partners

San Francisco, California

5 people0 investments

Possible Ventures

Munich, Germany

4 people0 investments

INITIATE Ventures

United States

2 people0 investments